This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Cross-Examination Remove Evidence Remove Pharmaceuticals
article thumbnail

eDiscovery Vendor Voices in October 2024: The Rise of AI and Strategic Leadership Moves

Complex Discovery

NOVEMBER 3, 2024

Complete Legal also contributed to this month’s focus with their in-depth examination of client success strategies. Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy. Compliance and regulatory tools were also spotlighted this month.

Government and Public Sector 69
Government and Public Sector Cross-Examination Technology Energy and Utilities 69
article thumbnail

Federal Rule of Evidence 702: A Useful Rule (When It's Followed)

Evidence at Trial

SEPTEMBER 9, 2021

What is inadmissible character evidence (Rule 404(a)) to one judge might be admissible "other acts" evidence (Rule 404(b)) to another. Merrell Dow Pharmaceuticals, Inc. They and their parents sued Merrell Dow Pharmaceuticals, Inc. And when it comes to expert opinion testimony, there can be even more uncertainty.

Evidence 52
Evidence Expert Testimony Admissibility Cross-Examination 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024